ARCHIVES

FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March.

This article is from The Cancer Letter archive.

Vol. 31 No. 03 | January 21, 2005

Download PDF Visit The Full Archive

Related Articles

NIH Investigating Cohn Records Leak

August 15, 1986

NIh Clinical Center Urged To Create Governing Board

March 15, 1996

Clinical Research; Duke Received Several Warnings from OPRR, Letters Indicate

May 14, 1999

In Brief: UC Irvine Wins Grant For Trial Of One-Visit Cervical Cancer Screening, Treatment

November 6, 1998

Tobacco Use Research Centers Funded

October 22, 1999

New Trial For Metastatic Colorectal Cancer Testing Vaccine-Chemotherapy Combination

March 29, 2002